This summary covers recent health news highlights, including Gilead's Trodelvy failing in a bladder cancer trial, Pfizer's optimistic sales forecast for Lorbrena, U.S. lawmakers' concerns about GenScript's China links, FDA's cautious stance on MDMA for PTSD, and the EU's recommendation for Valneva's chikungunya vaccine.